(Q44480572)

English

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

Frederick G Hayden

9

object named as

Frederick G Hayden

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

object named as

Maria Zambon

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kathleen Neuzil

11

object named as

Kathleen M Neuzil

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Stefan Gravenstein

4

object named as

Stefan Gravenstein

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Eric A F Simões

13

object named as

Eric A F Simões

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Janet E McElhaney

10

object named as

Janet E McElhaney

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Geoffrey J Gorse

7

object named as

Geoffrey J Gorse

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Ann R Falsey

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Edward E Walsh

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Jose Capellan

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Eddy Yau

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Robert Edelman

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kristen L Nichol

12

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Peter F Wright

14

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Valérie M-P Sales

15

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

198

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1317-1326

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Respiratory syncytial virus and parainfluenza virus

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Respiratory syncytial virus infections in previously healthy working adults

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Respiratory syncytial virus or influenza?

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Respiratory syncytial virus infection in elderly and high-risk adults

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

The future of respiratory syncytial virus vaccine development

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Risk factors for severe respiratory syncytial virus infection in elderly persons

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registry

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Experimental infection of humans with A2 respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Age related differences in humoral immune response to respiratory syncytial virus infection in adults

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Serum antibody decay in adults following natural respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Influenza-associated hospitalizations in the United States

1 reference

https://api.crossref.org/works/10.1086%2F592168

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44480572&oldid=2025305479"